CVRdatabase
Menu

Orifarm A/S

Public limited companyCVR 26058708Odense SActive

Orifarm A/S is a public limited company, based in Odense S, active in wholesale of pharmaceutical goods and nursing supplies, founded in 2001. Net profit fell 35% from 2024 to 2025, ending at DKK 9.7m. With 39 employees, the company is about 4 times larger than the industry median. Equity fell to DKK 44m in 2025.

Follow
PDF reportCompare

Key figures · financial year 2025

RevenueDKK 1.2bn−4% vs. 2024
Net profitDKK 9.7m−34.6% vs. 2024
EquityDKK 44m−18.3% vs. 2024
Employees39latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • Revenue fell 4% (2024 → 2025), to DKK 1.2bn.
  • Net profit fell 35% (2024 → 2025), to DKK 9.7m.
  • Equity fell 18% (2024 → 2025), to DKK 44m.

Employees

  • 2 fewer employees than a year earlier: 39 (08/2026) against 41 (08/2025).

Management and owners, last 24 months

  • New in management: Hans Carl Bøgh-Sørensen (chair of the board, 17/03/2025), Mads Fink Eriksen (board member, 17/03/2025) and Nicki Lund Kristensen (board member, 20/10/2025).
  • Stepped down: Hans Carl Bøgh-Sørensen (board member, 16/03/2025), Birgitte Bøgh-Sørensen (board member, 02/06/2026) and Erik Sandberg (chair of the board, 17/03/2025).

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

DKK 0DKK 10mDKK 20mDKK 30mDKK 40mDKK 50mDKK 60mDKK 70mDKK 80m202020212022202320242025
EquityNet profit
Financial figures for Orifarm A/S
202020212022202320242025Change
Revenue1,180,9121,493,6221,404,7981,575,9461,223,7771,174,659−4%
Gross profit35,44719,49020,15527,63523,23123,018−0.9%
Operating profit (EBIT)10,63414,09614,04715,76215,29514,207−7.1%
Profit before tax8,83311,02013,21723,85619,00112,658−33.4%
Net profit6,5638,1909,94118,87414,8659,727−34.6%
Total assets195,124195,390421,634301,842150,368148,121−1.5%
Equity42,25247,44257,38276,25653,92144,048−18.3%
Liabilities150,276145,810362,313223,57194,065102,063+8.5%
Average number of employees424034373837−2.6%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report.

Download the figures as CSV · free with an account, amounts in whole DKK

DKK 0DKK 5mDKK 10mDKK 15mDKK 20mDKK 25mDKK 30mDKK 35m202020212022202320242025
Gross profitMedian, the industry (232 companies)

Signals from the financial statements

calculated from the 2025 figures

  • Profit for five years in a row

    Net result has been positive in 2021–2025.

    How is this calculated?

    Net result is positive in the five latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for Orifarm A/S
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202528/05/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202412/06/2025The companyPDFXBRL
202301/01/2023 – 31/12/202310/06/2024The companyPDFXBRL
202201/01/2022 – 31/12/202207/06/2023The companyPDFXBRL
202101/01/2021 – 31/12/202105/07/2022The companyPDFXBRL
202001/01/2020 – 31/12/202014/06/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
01020304009/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/2608/26
Employees

Position in the industry

232 companies in the database

Comparison with the other companies in wholesale of pharmaceutical goods and nursing supplies based on the latest financial year.

Gross profitDKK 23mNo. 89 of 232
Better than 62% of the companies in the industry
EquityDKK 44mNo. 51 of 232
Better than 78% of the companies in the industry
Number of employees39No. 44 of 232
Better than 81% of the companies in the industry

Industry median: gross profit DKK 11.2m, net profit DKK 1.8m, equity DKK 9.6m, 9 employees.

DKK 100kDKK 1.4mDKK 19.1mDKK 263.2mDKK 1.5bnHere
Distribution of gross profit for 225 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with 20–49 employees9,922 companies in the comparison
No. 2,270of 9,892
Better than 77%
No. 802of 9,922
Better than 92%
Same industry and 20–49 employees47 companies in the comparison
No. 38of 47
Better than 20%
No. 17of 47
Better than 65%
Companies that are between 15 and 29 years old24,910 companies in the comparison
No. 2,985of 24,791
Better than 88%
No. 2,556of 24,909
Better than 90%
All companies of type A/S18,025 companies in the comparison
No. 5,362of 17,786
Better than 70%
No. 3,885of 18,024
Better than 78%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Wholesale of pharmaceutical goods and nursing supplies
Gross profit
  1. Orifarm A/SDKK 23m
  2. Ambu A/SDKK 3.6bn
  3. Stada Nordic ApSDKK 687m
Net profit
  1. Orifarm A/SDKK 9.7m
  2. Ambu A/SDKK 609m
  3. Stada Nordic ApSDKK 54.6m
Equity
  1. Orifarm A/SDKK 44m
  2. Ambu A/SDKK 6bn
  3. Stada Nordic ApSDKK 346.3m
Employees
  1. Orifarm A/S39
  2. Ambu A/S619
  3. Stada Nordic ApS51

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • Orifarm Pi A/S100%
Orifarm A/S

Management

4 active registrations

Executive management

Executive management at Orifarm A/S
NameRoleAppointed
Thomas BrandhofCEO01/02/2019

Board of directors

Board of directors at Orifarm A/S
NameRoleAppointed
Hans Carl Bøgh-SørensenChair of the board17/03/2025
Mads Fink EriksenBoard member17/03/2025
Nicki Lund KristensenBoard member20/10/2025
Founders
Henrik Steen Jensen, Steffen Ebdrup, Erik Jensen
Former management (20)
Former management at Orifarm A/S
NameRoleAppointedResigned
Henrik Steen JensenBoard member01/04/200101/11/2001
Steffen EbdrupBoard member01/04/200101/11/2001
Erik JensenBoard member01/04/200101/11/2001
Erik JensenDirector01/04/200101/11/2001
Ole Michael FriisChair of the board01/11/200120/10/2003
Niels ThorborgBoard member01/11/200131/05/2003
Per Munk LaustsenBoard member20/10/200314/04/2008
John Morell FrellsenBoard member20/10/200327/01/2005
Hans Carl Bøgh-SørensenCEO27/01/200521/12/2012
Anders Carl NorstrandBoard member27/01/200521/12/2012
Ole IbsenBoard member15/04/200805/07/2012
Hans Christian Eberhard Groth TeisenBoard member05/07/201209/04/2014
Hans Carl Bøgh-SørensenBoard member21/12/201216/03/2025
Erik SandbergCEO21/12/201209/04/2014
Birgitte Bøgh-SørensenBoard member09/04/201402/06/2026
Erik SandbergChair of the board09/04/201417/03/2025
Jens Peter NielsenCEO09/04/201427/08/2015
Anna Rehman LinderBoard member09/04/201427/08/2015
Jens Peter NielsenBoard member27/08/201501/02/2019
Tine Søndergaard JensenCEO27/08/201501/02/2019

Signing rule: Selskabet tegnes af den administrerende direktør og et bestyrelsesmedlem i forening eller af to bestyrelsesmedlemmer i forening.

Address and production units

2 active production units

Energivej 15
5260 Odense S

Odense Municipality · Postcode 5260

Other companies at the address (5)

Production units
Production unitAddressEmployeesP number
ORIFARM A/SEnergivej 15, Lindved, 5260 Odense S391008464568
ORIFARM A/SGyngemose Parkvej 50, 6, 2860 Søborg11026705165

Purpose

Selskabets formål er at foretage salg af parallelimporterede lægemidler i Danmark.

The purpose is quoted from the register in Danish.

Changes year by year

61 registered events
20262 changesmanagement 1 · accounts 1
  • Birgitte Bøgh-Sørensen stepped down as board member
  • Annual report for 2025 published
20256 changesmanagement 5 · accounts 1
  • Nicki Lund Kristensen appointed board member
  • Annual report for 2024 published
  • Mads Fink Eriksen appointed board member
  • Hans Carl Bøgh-Sørensen appointed chair of the board
  • Erik Sandberg stepped down as chair of the board
  • Hans Carl Bøgh-Sørensen stepped down as board member
20241 changeaccounts 1
  • Annual report for 2023 published
20231 changeaccounts 1
  • Annual report for 2022 published
20222 changesaccounts 1 · address 1
  • Annual report for 2021 published
  • Moved to Energivej 15, Lindved, 5260 Odense S
20212 changesaddress 1 · accounts 1
  • Moved to Energivej 15, Lindved, 5260 Odense S
  • Annual report for 2020 published
20201 changeaddress 1
  • Moved to Energivej 15, Lindved, 5260 Odense S
20194 changesaddress 1 · management 3
  • Moved to Energivej 15, Lindved, 5260 Odense S
  • Thomas Brandhof appointed ceo
  • Jens Peter Nielsen stepped down as board member
  • Tine Søndergaard Jensen stepped down as ceo
20154 changesmanagement 4
  • Jens Peter Nielsen appointed board member
  • Tine Søndergaard Jensen appointed ceo
  • Anna Rehman Linder stepped down as board member
  • Jens Peter Nielsen stepped down as ceo
20146 changesmanagement 6
  • Erik Sandberg appointed chair of the board
  • Anna Rehman Linder appointed board member
  • Jens Peter Nielsen appointed ceo
  • Birgitte Bøgh-Sørensen appointed board member
  • Erik Sandberg stepped down as ceo
  • Hans Christian Eberhard Groth Teisen stepped down as board member
20126 changesmanagement 6
  • Hans Carl Bøgh-Sørensen appointed board member
  • Erik Sandberg appointed ceo
  • Hans Carl Bøgh-Sørensen stepped down as ceo
  • Anders Carl Norstrand stepped down as board member
  • Hans Christian Eberhard Groth Teisen appointed board member
  • Ole Ibsen stepped down as board member
20082 changesmanagement 2
  • Ole Ibsen appointed board member
  • Per Munk Laustsen stepped down as board member
20053 changesmanagement 3
  • Hans Carl Bøgh-Sørensen appointed ceo
  • Anders Carl Norstrand appointed board member
  • John Morell Frellsen stepped down as board member
20035 changesmanagement 4 · ownership 1
  • Per Munk Laustsen appointed board member
  • John Morell Frellsen appointed board member
  • Ole Michael Friis stepped down as chair of the board
  • ORIFARM PI A/S registered as owner (100%)
  • Niels Thorborg stepped down as board member
20024 changescapital 2 · merger 1 · name 1
  • Share capital changed from 5,000,000 DKK to 5,100,000 DKK
  • Merger registered in CVR
  • Name changed from JUT NR. 2181 A/S to ORIFARM A/S
  • Share capital changed from 500,000 DKK to 5,000,000 DKK
200112 changesaddress 1 · management 10 · founded 1
  • Moved to Energivej 15, Lindved, 5260 Odense S
  • Niels Thorborg appointed board member
  • Ole Michael Friis appointed chair of the board
  • Henrik Steen Jensen stepped down as board member
  • Erik Jensen stepped down as director
  • Erik Jensen stepped down as board member
  • Steffen Ebdrup stepped down as board member
  • Registered as JUT NR. 2181 A/S
  • Henrik Steen Jensen appointed board member
  • Erik Jensen appointed director
  • Erik Jensen appointed board member
  • Steffen Ebdrup appointed board member

Related companies

Same industry in Odense

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction